EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MAD1 upregulation sensitizes to inflammation-mediated tumor formation

Sarah E Copeland iD, Santina M Snow, Jun Wan iD, Kristina A Matkowskyj iD, Richard B Halberg, Beth A Weaver iD

PLOS Genetics · 2024

DOI: 10.1371/journal.pgen.1011437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Sarah E Copeland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Pharmacology Graduate Training Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Colonic Neoplasms, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, University of Wisconsin-Madison UW2020, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitotic Arrest Deficient 1 (gene name MAD1L1 ), an essential component of the mitotic spindle assembly checkpoint, is frequently overexpressed in colon cancer, which correlates with poor disease-free survival. MAD1 upregulation induces two phenotypes associated with tumor promotion in tissue culture cells–low rates of chromosomal instability (CIN) and destabilization of the tumor suppressor p53. Using CRISPR/Cas9 gene editing, we generated a novel mouse model by inserting a doxycycline (dox)-inducible promoter and HA tag into the endogenous mouse Mad1l1 gene, enabling inducible expression of HA-MAD1 following exposure to dox in the presence of the reverse tet transactivator (rtTA). A modest 2-fold overexpression of MAD1 in murine colon resulted in decreased p53 expression and increased mitotic defects consistent with CIN. After exposure to the colon-specific inflammatory agent dextran sulfate sodium (DSS), 31% of mice developed colon lesions, including a mucinous adenocarcinoma, while none formed in control animals. Lesion incidence was particularly high in male mice, 57% of which developed at least one hyperplastic polyp, adenoma or adenocarcinoma in the colon. Notably, mice expressing HA-MAD1 also developed lesions in tissues in which DSS is not expected to induce inflammation. These findings demonstrate that MAD1 upregulation is sufficient to promote colon tumorigenesis in the context of inflammation in immune-competent mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsColonic NeoplasmsInflammationAnimalsFemaleHumansMaleMiceCarcinogenesisChromosomal InstabilityCRISPR-Cas SystemsDextran SulfateGene Expression Regulation, NeoplasticNuclear ProteinsTumor Suppressor Protein p53Up-Regulation

Substanzen

Cell Cycle ProteinsDextran SulfateNuclear ProteinsTrp53 protein, mouseTumor Suppressor Protein p53Mad1l1 protein, mouse

Autor:innen und Institutionen

  • Molecular and Cellular Pharmacology Graduate Training Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Cancer Biology Graduate Training Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Department of Oncology/McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Physiology Graduate Training Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.

ORCID-Profile: Sarah E Copeland, Jun Wan, Kristina A Matkowskyj, Beth A Weaver

Förderung

  • NCI NIH HHS
  • University of Wisconsin-Madison UW2020
  • National Institutes of Health
  • Wisconsin Dual Sports Riders

Zitieren

APA

Copeland, S. E., Snow, S. M., Wan, J., Matkowskyj, K. A., Halberg, R. B., & Weaver, B. A. (2024). MAD1 upregulation sensitizes to inflammation-mediated tumor formation. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011437

Vancouver

Copeland SE, Snow SM, Wan J, Matkowskyj KA, Halberg RB, Weaver BA. MAD1 upregulation sensitizes to inflammation-mediated tumor formation. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011437

BibTeX
@article{Copeland2024,
  author = {Copeland, Sarah E and Snow, Santina M and Wan, Jun and Matkowskyj, Kristina A and Halberg, Richard B and Weaver, Beth A},
  title = {MAD1 upregulation sensitizes to inflammation-mediated tumor formation},
  journal = {PLOS Genetics},
  year = {2024},
  doi = {10.1371/journal.pgen.1011437}
}
Kostenlos starten →